Hiroyuki Momota

2.0k total citations
39 papers, 1.5k citations indexed

About

Hiroyuki Momota is a scholar working on Molecular Biology, Genetics and Neurology. According to data from OpenAlex, Hiroyuki Momota has authored 39 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 22 papers in Genetics and 10 papers in Neurology. Recurrent topics in Hiroyuki Momota's work include Glioma Diagnosis and Treatment (22 papers), Hedgehog Signaling Pathway Studies (6 papers) and Brain Metastases and Treatment (6 papers). Hiroyuki Momota is often cited by papers focused on Glioma Diagnosis and Treatment (22 papers), Hedgehog Signaling Pathway Studies (6 papers) and Brain Metastases and Treatment (6 papers). Hiroyuki Momota collaborates with scholars based in Japan, United States and Taiwan. Hiroyuki Momota's co-authors include Eric C. Holland, Dolores Hambardzumyan, Alicia Pedraza, Cameron Brennan, Adesh Tandon, Eric C. Holland, Tatsuya Ozawa, Toshihiko Wakabayashi, Atsushi Natsume and Yasuji Miyakita and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Hiroyuki Momota

39 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hiroyuki Momota Japan 19 846 669 357 246 233 39 1.5k
Theodore Nicolaides United States 25 1.0k 1.2× 811 1.2× 313 0.9× 276 1.1× 367 1.6× 56 1.8k
Karisa C. Schreck United States 16 946 1.1× 505 0.8× 290 0.8× 418 1.7× 140 0.6× 55 1.4k
Danielle Schüler France 4 614 0.7× 984 1.5× 476 1.3× 220 0.9× 216 0.9× 5 1.4k
Andrea M. Griesinger United States 17 759 0.9× 439 0.7× 196 0.5× 300 1.2× 140 0.6× 37 1.3k
Fredrik J. Swartling Sweden 21 867 1.0× 538 0.8× 358 1.0× 223 0.9× 132 0.6× 53 1.3k
Jana Karásková Canada 17 870 1.0× 248 0.4× 333 0.9× 379 1.5× 115 0.5× 22 1.4k
Lucie Karayan‐Tapon France 23 794 0.9× 603 0.9× 524 1.5× 467 1.9× 72 0.3× 61 1.6k
David Tran United States 20 528 0.6× 568 0.8× 255 0.7× 485 2.0× 105 0.5× 39 1.4k
Mirjam Hermisson Germany 14 614 0.7× 504 0.8× 232 0.6× 229 0.9× 70 0.3× 17 1.1k
Avadhut D. Joshi United States 15 709 0.8× 436 0.7× 449 1.3× 238 1.0× 49 0.2× 26 1.2k

Countries citing papers authored by Hiroyuki Momota

Since Specialization
Citations

This map shows the geographic impact of Hiroyuki Momota's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroyuki Momota with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroyuki Momota more than expected).

Fields of papers citing papers by Hiroyuki Momota

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroyuki Momota. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroyuki Momota. The network helps show where Hiroyuki Momota may publish in the future.

Co-authorship network of co-authors of Hiroyuki Momota

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroyuki Momota. A scholar is included among the top collaborators of Hiroyuki Momota based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroyuki Momota. Hiroyuki Momota is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ohkawa, Yuki, Pu Zhang, Hiroyuki Momota, et al.. (2021). Lack of GD3 synthase (St8sia1) attenuates malignant properties of gliomas in genetically engineered mouse model. Cancer Science. 112(9). 3756–3768. 17 indexed citations
2.
Ohkawa, Yuki, Hiroyuki Momota, Akira Kato, et al.. (2015). Ganglioside GD3 Enhances Invasiveness of Gliomas by Forming a Complex with Platelet-derived Growth Factor Receptor α and Yes Kinase. Journal of Biological Chemistry. 290(26). 16043–16058. 63 indexed citations
3.
Momota, Hiroyuki, Seiichi Kato, Masazumi Fujii, et al.. (2015). Primary peripheral T-cell lymphoma, not otherwise specified, of the central nervous system in a child. Brain Tumor Pathology. 32(4). 281–285. 3 indexed citations
4.
Momota, Hiroyuki, Masazumi Fujii, Yoshie Shimoyama, et al.. (2014). Papillary glioneuronal tumor with a high proliferative component and minigemistocytes in a child. Neuropathology. 34(5). 484–490. 3 indexed citations
5.
Iwami, Kenichiro, Hiroyuki Momota, Masazumi Fujii, et al.. (2014). Anaplastic meningioma with rapid growth after omental flap transposition: a case report and experimental study. Brain Tumor Pathology. 32(2). 137–144. 9 indexed citations
6.
Motomura, Kazuya, Atsushi Natsume, Reiko Watanabe, et al.. (2012). Immunohistochemical analysis‐based proteomic subclassification of newly diagnosed glioblastomas. Cancer Science. 103(10). 1871–1879. 37 indexed citations
7.
Momota, Hiroyuki, Yoshitaka Narita, Yasuji Miyakita, & Soichiro Shibui. (2012). Intravascular lymphoma of the central nervous system presenting as multiple cerebral infarctions.. PubMed. 74(3-4). 353–8. 12 indexed citations
8.
Ohka, Fumiharu, Atsushi Natsume, Kazuya Motomura, et al.. (2011). The Global DNA Methylation Surrogate LINE-1 Methylation Is Correlated with MGMT Promoter Methylation and Is a Better Prognostic Factor for Glioma. PLoS ONE. 6(8). e23332–e23332. 89 indexed citations
9.
Motomura, Kenta, et al.. (2011). Clinical experience of intravenous temozolomide therapy for gliomas.. Journal of Clinical Oncology. 29(15_suppl). e12523–e12523. 1 indexed citations
10.
Momota, Hiroyuki, Kenichiro Iwami, Masazumi Fujii, et al.. (2011). Rhabdoid glioblastoma in a child: case report and literature review. Brain Tumor Pathology. 28(1). 65–70. 22 indexed citations
11.
Suzuki, Kengo, Hiroyuki Momota, Akiko Tonooka, et al.. (2010). Glioblastoma simultaneously present with adjacent meningioma: case report and review of the literature. Journal of Neuro-Oncology. 99(1). 147–153. 40 indexed citations
12.
Momota, Hiroyuki, Yoshitaka Narita, Yuko Matsushita, Yasuji Miyakita, & Soichiro Shibui. (2010). p53 abnormality and tumor invasion in patients with malignant astrocytoma. Brain Tumor Pathology. 27(2). 95–101. 18 indexed citations
13.
Momota, Hiroyuki, Yoshitaka Narita, Akiko Miyagi Maeshima, et al.. (2009). Prognostic value of immunohistochemical profile and response to high-dose methotrexate therapy in primary CNS lymphoma. Journal of Neuro-Oncology. 98(3). 341–348. 28 indexed citations
14.
Momota, Hiroyuki & Eric C. Holland. (2009). Mouse models of CNS embryonal tumors. Brain Tumor Pathology. 26(2). 43–50. 12 indexed citations
15.
Becher, Oren J., Dolores Hambardzumyan, Elena I. Fomchenko, et al.. (2008). Gli Activity Correlates with Tumor Grade in Platelet-Derived Growth Factor–Induced Gliomas. Cancer Research. 68(7). 2241–2249. 151 indexed citations
16.
Momota, Hiroyuki, Alan H. Shih, Mark Edgar, & Eric C. Holland. (2008). c-Myc and β-catenin cooperate with loss of p53 to generate multiple members of the primitive neuroectodermal tumor family in mice. Oncogene. 27(32). 4392–4401. 37 indexed citations
17.
18.
Momota, Hiroyuki & Eric C. Holland. (2005). Bioluminescence technology for imaging cell proliferation. Current Opinion in Biotechnology. 16(6). 681–686. 18 indexed citations
19.
Momota, Hiroyuki, Shingo Ichimiya, Tatsuru Ikeda, et al.. (2003). Immunohistochemical analysis of the p53 family members in human craniopharyngiomas. Brain Tumor Pathology. 20(2). 73–77. 16 indexed citations
20.
Ichimiya, Shingo, Takashi Kojima, Hiroyuki Momota, et al.. (2002). p73 Is Expressed in Human Thymic Epithelial Cells. Journal of Histochemistry & Cytochemistry. 50(4). 455–462. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Theodore Nicolaides Breakdown of academic impact, for papers by Karisa C. Schreck Breakdown of academic impact, for papers by Danielle Schüler Breakdown of academic impact, for papers by Andrea M. Griesinger Breakdown of academic impact, for papers by Fredrik J. Swartling Breakdown of academic impact, for papers by Jana Karásková Breakdown of academic impact, for papers by Lucie Karayan‐Tapon Breakdown of academic impact, for papers by David Tran Breakdown of academic impact, for papers by Mirjam Hermisson Breakdown of academic impact, for papers by Avadhut D. Joshi
Rankless by CCL
2026